(Q26828933)

Guilherme Godoy

series ordinal

2

1 reference

Gilad E. Amiel

series ordinal

3

1 reference

Seth P. Lerner

series ordinal

4

1 reference

language of work or name

1 reference

September 2012

1 reference

1 reference

110

1 reference

PubMed

page(s)

630-6

1 reference

PubMed

issue

5

1 reference

PubMed

cites work

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10884.X

Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10884.X

EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10884.X

Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10884.X

Differences between local and review urinary cytology in diagnosis of bladder cancer. An interobserver multicenter analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10884.X

Molecular circuits of apoptosis regulation and cell division control: the survivin paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10884.X

Survivin: a promising biomarker for detection and prognosis of bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10884.X

A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10884.X

The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10884.X

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10884.X

Meta-DiSc: a software for meta-analysis of test accuracy data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10884.X

Urine detection of survivin is a sensitive marker for the noninvasive diagnosis of bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10884.X

The expression and significance of survivin mRNA in urinary bladder carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10884.X

Quantitative analysis of survivin mRNA expression in urine and tumor tissue of bladder cancer patients and its potential relevance for disease detection and prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10884.X

Detection of newly diagnosed bladder cancer, bladder cancer recurrence and bladder cancer in patients with hematuria using quantitative rt-PCR of urinary survivin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10884.X

Expression of HYAL1 and survivin RNA as diagnostic molecular markers for bladder cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10884.X

Clinical experience with survivin as a biomarker for urothelial bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10884.X

Patient opinion of urinary tests versus flexible urethrocystoscopy in follow-up examination for superficial bladder cancer: a utility analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10884.X

Diagnostic tests 4: likelihood ratios

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10884.X

Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10884.X

Ruling a diagnosis in or out with "SpPIn" and "SnNOut": a note of caution

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10884.X

The value of combined use of survivin, cytokeratin 20 and mucin 7 mRNA for bladder cancer detection in voided urine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10884.X

Urine detection of survivin and diagnosis of bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10884.X

7 January 2021

Preliminary study of diagnostic utility of molecular beacons in bladder cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10884.X

7 January 2021

Evaluation of survivin reverse transcriptase-polymerase chain reaction for noninvasive detection of bladder cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10884.X

7 January 2021

Detection of urine survivin in 40 patients with bladder cancer

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2011.10884.X

7 January 2021

10.1111/J.1464-410X.2011.10884.X

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

3923352

3923352

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference